Nasdaq - QCOR

 Healthcare  Biotechnology  Market Cap Billion  Aggressive Growth Stock  Anaheim, California  557 Employees

 What Does This Company Do? Questcor Pharmaceuticals Inc is a biopharmaceutical company, that provides prescription drugs for the treatment of multiple sclerosis, nephrotic syndrome, and infantile spasms indications. ◦ Acthar Gel- treatment of acute exacerbations of multiple sclerosis ◦ Acthar - $621 Million in sales – approved for 19 conditions ◦ Acthar Phase II trials- Treatment for ALS – FDA request for orphan designation

 Roche Holding  Novo Nordisk  Gilead Science Inc.  Lundbeck  Novartis  Sanofi

 Low debt (10% of Cap’l)  Relatively Low PE (16) and pays dividend (1.70%) (raising quarterly dividend by 20%)  VL projects 11% - 22% return  Has expanding use of Acthar with great success  Mid Cap  Named Forbes Best Small Public Company (5yr est. sales – 51%, est. growth 41%)  MS rated 5.0 – Buy  Yahoo 1.5 – Buy  Motley Fool Quote “ Simply put, Questcor looks very cheap”

 Tremendous Growth – 52 weeks - $19.90 – $74.76  Business appears to be focused on the development of one major drug  Club portfolio contains 3 biotech stocks(?)  Zacks - 3  VL “some reimbursement concerns”

“long term investors should consider these shares”

Buy